✦ LIBER ✦

Integrating the Anti–VEGF-A Humanized Monoclonal Antibody Bevacizumab with Chemotherapy in Advanced Colorectal Cancer

✍ Scribed by Herbert Hurwitz

Book ID: 119934963
Publisher: CIG Media Group, LP.
Year: 2004
Tongue: English
Weight: 133 KB
Volume: 4
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2004.s.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab, a humanized anti-angiogenic

Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer

✍ I. Krämer; H.-P. Lipp 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Biodistribution of humanized anti-VEGF m

Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice

✍ Yasumichi Yagi; Sachio Fushida; Shinichi Harada; Tomoya Tsukada; Jun Kinoshita; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 501 KB

Phase I study of anti-VEGF monoclonal an

Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers

✍ Wheler, Jennifer J.; Janku, Filip; Falchook, Gerald S.; Jackson, Tiffiny L.; Fu, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 386 KB

Safety, pharmacokinetics and pharmacodyn

Safety, pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody, KRN330, in patients with advanced colorectal cancer

✍ Infante, Jeffrey R.; Bendell, Johanna C.; Goff, Laura Williams; Jones, Suzanne F 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 511 KB

Cetuximab, a chimeric human mouse anti-e

Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer

✍ Galizia, G; Lieto, E; De Vita, F; Orditura, M; Castellano, P; Troiani, T; Impera 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 129 KB

A Human Monoclonal Anti-ANG2 Antibody Le

A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

✍ Brown, J. L.; Cao, Z. A.; Pinzon-Ortiz, M.; Kendrew, J.; Reimer, C.; Wen, S.; Zh 📂 Article 📅 2010 🏛 American Association for Cancer Research 🌐 English ⚖ 815 KB